Coronavirus disease 2019 pandemic related changes in pediatric patient numbers in Tokushima, Japan

Ayumu Tominaga1, Yoshiro Mori1, Kazumi Nakagawa1

  • 1Department of Public Health, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.

Insights

The COVID-19 pandemic significantly reduced pediatric inpatient visits and outpatient visits in Tokushima, Japan. Inpatient numbers saw a larger decrease, impacting children

Area of Science:

  • Pediatric healthcare utilization
  • Epidemiology of infectious diseases
  • Public health policy impact

Background:

  • The COVID-19 pandemic has profoundly affected global healthcare systems.
  • Understanding its impact on pediatric care is crucial for public health planning.
  • Previous studies indicate varied effects on healthcare access and utilization.

Purpose of the Study:

  • To investigate the impact of the COVID-19 pandemic on pediatric inpatient and outpatient visits.
  • To analyze changes in healthcare utilization among children under 15 in Tokushima Prefecture, Japan.
  • To compare pre-pandemic (FY2019) and pandemic (FY2020) healthcare-seeking behaviors.

Main Methods:

  • Analysis of medical claims data for children (<15 years) insured by National Health Insurance in Tokushima.
  • Calculation of mean monthly inpatient and outpatient visits per 1,000 children for FY2019 and FY2020.
  • Use of multivariable negative binomial regression to determine incident rate ratios (IRRs).

Main Results:

  • A significant decrease in pediatric inpatient visits was observed during FY2020 (IRR=0.58, p<0.05).
  • Pediatric outpatient visits showed a non-significant decrease during FY2020 (IRR=0.79, p>0.05).
  • The reduction in inpatient visits was more pronounced than that for outpatient visits.

Conclusions:

  • The COVID-19 pandemic led to a notable decline in pediatric healthcare utilization, particularly for inpatient services.
  • Findings suggest altered healthcare-seeking behaviors and reduced medical service use among children during the pandemic.
  • Further research is needed to understand long-term effects and inform pediatric healthcare strategies.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
100
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
191
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
108